[Erythropoietin and hypoxia responsive system].
Imagawa
S
S
Department of Hematology, Jichi Medical School, Kawachi-gun, Japan. simagawa@jichi.ac.jp
D000740:Anemia / Q000209:etiology / Q000628:therapy; D000818:Animals; D051778:Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; D004268:DNA-Binding Proteins / Q000502:physiology; D004921:Erythropoietin / Q000235:genetics; D018913:Event-Related Potentials, P300 / Q000502:physiology; D005786:Gene Expression Regulation; D015316:Genetic Therapy; D051557:Hepatocyte Nuclear Factor 4; D006801:Humans; D000860:Hypoxia / Q000235:genetics; D051793:Hypoxia-Inducible Factor 1; D051795:Hypoxia-Inducible Factor 1, alpha Subunit; D007676:Kidney Failure, Chronic / Q000150:complications; D009687:Nuclear Proteins / Q000502:physiology; D010750:Phosphoproteins / Q000502:physiology; D014157:Transcription Factors / Q000502:physiology; D014158:Transcription, Genetic; D019323:omega-N-Methylarginine
D051778:Basic Helix-Loop-Helix Leucine Zipper Transcription Factors; D004268:DNA-Binding Proteins; C497442:HIF1A protein, human; D051557:Hepatocyte Nuclear Factor 4; D051793:Hypoxia-Inducible Factor 1; D051795:Hypoxia-Inducible Factor 1, alpha Subunit; C403128:MLX protein, human; D009687:Nuclear Proteins; D010750:Phosphoproteins; D014157:Transcription Factors; D004921:Erythropoietin; D019323:omega-N-Methylarginine